Work

Estrogen receptor-positive (ER+) metastatic breast cancer (MBC) patients (pts) with extreme responses (ERs) to capecitabine having tumors with genomic alterations in DNA repair and chromatin remodeling genes.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.555

Authors: Maren K. Levin, Kai Wang, Roman Yelensky, Ying Cao, Corinne Ramos, Glenn D. Hoke, John E. Pippen, Joanne Lorraine Blum, Barry Don Brooks, Gary A. Palmer, Norma Alonzo Palma, Sohail Balasubramanian, Jeffrey S. Ross, Joyce O'Shaughnessy

Institutions: Foundation Medicine (United States), Albany Medical College

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2598390325

Cites:

Cited by:

Related to: 10